Men's Health News

RSS

Common hormone therapy to treat prostate cancer may increase dementia risk in men

A common hormone therapy to treat prostate cancer may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported in a study published online today in JAMA Oncology.

14 Oct 2016

Snus use linked to increased risk of premature death among prostate cancer patients

The smokeless tobacco product snus, which is used mainly in Sweden but also is sold in the U.S., may increase the risk that men with prostate cancer will die from their disease, and the risk that they'll die prematurely from any cause, according to a new study led by researchers at Harvard T.H. Chan School of Public Health.

13 Oct 2016

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

African-American and Hispanic men in the United States are less likely to receive therapy for prostate cancer compared to Caucasian men — even when they have more aggressive disease, according to new research from Roswell Park Cancer Institute and Vanderbilt University Medical Center.

7 Oct 2016

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

Controversy over prostate cancer screening guidelines that discourage use of PSA tests did not significantly reduce use of the test, a five-year review of more than 275,000 visits at UT Southwestern Medical Center showed.

6 Oct 2016

Has human lifespan reached its maximum limit?

By Sally Robertson, BSc According to a study published in Nature, the maximum human lifespan is fixed, has already been reached and is not likely to increase as time goes on.

6 Oct 2016

C-11 choline PET and MRI help physicians map patterns of prostate cancer recurrence after surgery

A team of Mayo Clinic researchers has, for the first time, successfully mapped patterns of prostate cancer recurrence, following surgery. Using C-11 choline PET imaging and multiparametric MRI, researchers found an anatomically diverse pattern of recurrence, which may help optimize treatment of patients whose prostate cancer returns after surgery.

6 Oct 2016

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Only four in 10 gay and bisexual men in Baltimore without HIV are aware that pre-exposure prophylaxis medication (PrEP) may significantly reduce their risk of contracting the virus, even those who had recently visited a doctor or been tested for a sexually transmitted disease, new Johns Hopkins Bloomberg School of Public Health research suggests.

5 Oct 2016

Vitamin E may reduce risk of pneumonia in nonsmoking elderly men

Administration of 50 mg per day of vitamin E decreased the risk of pneumonia in elderly male smokers by 72% after they quit smoking, according to a paper published in Clinical Interventions in Aging.

5 Oct 2016

Researchers confirm long persistence of Zika virus in semen and reveal its presence within spermatozoa

Recent work has shown that Zika virus persists in semen for up to 6 months after infection. In a correspondence published in The Lancet Infectious Diseases, the researchers, in addition to confirming its long persistence in semen (in this case for more than 130 days, i.e., over 4 months), reveal the presence of the virus even within spermatozoa.

4 Oct 2016

Living healthy lifestyle could benefit men with high genetic risk of developing bowel cancer

Men with a high genetic risk of developing bowel cancer over the next 25 years could have a lower risk of developing the disease if they also have a healthy lifestyle, according to a Cancer Research UK-funded study published in the journal Genetics in Medicine today (Thursday).

29 Sep 2016

Bioactive compound from neem plant shows promising effects on prostate cancer

A team of international researchers led by Associate Professor Gautam Sethi from the Department of Pharmacology at the Yong Loo Lin School of Medicine at the National University of Singapore has found that nimbolide, a bioactive terpenoid compound derived from Azadirachta indica or more commonly known as the neem plant, could reduce the size of prostate tumour by up to 70 per cent and suppress its spread or metastasis by half.

29 Sep 2016

Study examines benefits of hormonal therapy for prostate cancer patients with prior history of heart attack

In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack.

28 Sep 2016

Smoking fathers contribute to greater risk of early-onset asthma in offspring

A Norwegian study shows that asthma is three times more common in those who had a fAnchorather who smoked in adolescence than offspring who didn't.

28 Sep 2016

Researchers link RHOX gene mutations to infertility in men

The underlying cause of male infertility is unknown for 30 percent of cases. In a pair of new studies, researchers at University of California San Diego School of Medicine determined that the reproductive homeobox (RHOX) family of transcription factors — regulatory proteins that activate some genes and inactivate others — drive the development of stem cells in the testes in mice.

27 Sep 2016

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

For men with intermediate risk prostate cancer, radiation treatment with brachytherapy alone can result in similar cancer control with fewer long-term side effects, when compared to more aggressive treatment that combines brachytherapy with external beam therapy (EBT), according to research presented today at the 58th Annual Meeting the American Society for Radiation Oncology.

27 Sep 2016

Researchers identify, validate three distinct molecular subtypes of prostate cancer

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

New study reports both young men and women with ACS have good one-year prognosis

It has become commonly accepted that women do worse than men following a heart attack or other coronary event.

26 Sep 2016

One single genomic fingerprinting could potentially miss smaller, more aggressive prostate tumors

While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal.

22 Sep 2016

Study data does not support benefits of testosterone supplementation in men with ‘low T’

The prescription of testosterone supplementation for cardiovascular health, sexual function, physical function, mood, or cognitive function in men with "low T" is not supported by clinical trials data, conclude researchers who describe a review of more than 200 clinical trials published Sept. 21 in PLOS One.

22 Sep 2016

Duke researchers discover blood markers linked to drug-resistant tumor cells

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies.

21 Sep 2016

Men's Health News

Common hormone therapy to treat prostate cancer may increase dementia risk in men

Snus use linked to increased risk of premature death among prostate cancer patients

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

Has human lifespan reached its maximum limit?

C-11 choline PET and MRI help physicians map patterns of prostate cancer recurrence after surgery

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Vitamin E may reduce risk of pneumonia in nonsmoking elderly men

Researchers confirm long persistence of Zika virus in semen and reveal its presence within spermatozoa

Living healthy lifestyle could benefit men with high genetic risk of developing bowel cancer

Bioactive compound from neem plant shows promising effects on prostate cancer

Study examines benefits of hormonal therapy for prostate cancer patients with prior history of heart attack

Smoking fathers contribute to greater risk of early-onset asthma in offspring

Researchers link RHOX gene mutations to infertility in men

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Researchers identify, validate three distinct molecular subtypes of prostate cancer

New study reports both young men and women with ACS have good one-year prognosis

One single genomic fingerprinting could potentially miss smaller, more aggressive prostate tumors

Study data does not support benefits of testosterone supplementation in men with ‘low T’

Duke researchers discover blood markers linked to drug-resistant tumor cells

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News